Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $301,895.

  • Cumberland Pharmaceuticals' Share-based Compensation rose 6.40% to $81,262 in Q3 2025 from the same period last year, while for Sep 2025 it was $310,972, marking a year-over-year decrease of 3.12%. This contributed to the annual value of $301,895 for FY2024, which is 17.30% down from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' Share-based Compensation is $301,895, which was down 17.30% from $365,040 recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Share-based Compensation ranged from a high of $1.0 million in FY2020 and a low of $301,895 during FY2024.
  • Its 3-year average for Share-based Compensation is $371,479, with a median of $365,040 in 2023.
  • Data for Cumberland Pharmaceuticals' Share-based Compensation shows a maximum YoY plummeted of 39.68% (in 2022) over the last 5 years.
  • Cumberland Pharmaceuticals' Share-based Compensation (Yearly) stood at $1.0 million in 2020, then fell by 29.11% to $741,867 in 2021, then crashed by 39.68% to $447,503 in 2022, then dropped by 18.43% to $365,040 in 2023, then fell by 17.30% to $301,895 in 2024.